Parkinson's Disease Diagnosis and Treatment Market Growth, Innovations and Market Size Forecast 2035
According to market projections, the global Parkinson’s disease diagnosis and treatment market, valued at USD 7.49 billion in 2025, is anticipated to reach USD 17.57 billion by 2035, growing at a CAGR of 8.9% over the next decade. In 2025, medications led the Parkinson’s disease market with a 40% share, while North America dominated at 38%. Asia Pacific is set to grow fastest, with a 7.0% CAGR. Key players include Siemens Healthineers, Abbott, GE, AbbVie, Merck, Pfizer, Teva, Sun Pharma, Novartis, and Cerevel Therapeutics.
Last Updated : 05 August 2026
Category: Therapeutic Area
Insight Code: 5142
Format: PDF / PPT / Excel